Clinical Trials Browser

Not yet recruiting × INDUSTRY × Prostatic Neoplasms × Clear all

NCT07600554 2026-05-20

SWAP

Phase 1 Not yet recruiting

Prostatic Neoplasms

NCT07564102 2026-05-15

dMD-002 Pilot Study in Patients With Cavernous Nerve Injury Following Radical Prostatectomy

Phase 1/2 Not yet recruiting

Prostatic Neoplasms

NCT07590934 2026-05-15

PROSPECTOR

Phase 1/2 Not yet recruiting

Prostatic Neoplasms

NCT07569926 2026-05-06

Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Management of Prostate Cancer Following Negative or Equivocal PSMA (Prostate-Specific Membrane Antigen) PET Imaging at the Time of Biochemical Recurrence

Phase 4 Not yet recruiting

Prostatic Neoplasms

NCT07570966 2026-05-06

Study of ERW316 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors

Phase 1/2 Not yet recruiting

BreastGenitourinary

Breast Neoplasms, Prostatic Neoplasms

NCT07567521 2026-05-05

A Study of TRC003 in the Treatment of Patients With Progressive PSMA-positive mCRPC

Phase 1/2 Not yet recruiting

Prostatic Neoplasms

NCT07567846 2026-05-05

A Study Evaluating the Safety, Pharmacokinetics, and Preliminary Activity of GDC-1261 in Participants With Advanced or Metastatic Prostate Cancer

Phase 1/2 Not yet recruiting

Prostatic Neoplasms

NCT07560215 2026-05-01

PROMET-BR

Not yet recruiting

Prostatic Neoplasms

NCT07542379 2026-04-21

The Safety, Dosimetry and Efficacy of 177Lu-FC516 in Patients With Prostate Cancer

Phase EARLY_PHASE1 Not yet recruiting

Prostatic Neoplasms

NCT07543055 2026-04-21

A Phase 1 Study of BPX-601 CAR T-Cell Therapy in Adult Participants With Prostate Cancer That Has Returned, is Resistant to Treatment and Has Spread

Phase 1 Not yet recruiting

Neoplasm Metastasis, Prostatic Neoplasms, Recurrence

NCT07492381 2026-04-07

A Prospective, Single-Arm, Pilot Study of the ALPFA BPH PFA System in Men With Low, Intermediate and High-Risk Prostate Cancer

Phase NA Not yet recruiting

Prostatic Neoplasms

NCT07290998 2026-04-06

Alpha Radiation Emitters Device (DaRT) for the Treatment of Locally Recurrent Prostate Cancer

Phase NA Not yet recruiting

Prostatic Neoplasms

NCT07484269 2026-03-20

PULSE

Not yet recruiting

Prostatic Neoplasms

NCT07468396 2026-03-12

A Phase I Clinical Study of GLR2037 in Patients With Advanced Prostate Cancer

Phase 1 Not yet recruiting

Prostatic Neoplasms

NCT07454603 2026-03-06

PROSTest_STRAT

Not yet recruiting

Disease, Prostatic Neoplasms

NCT07455058 2026-03-06

VAPOR-LTR

Not yet recruiting

Prostatic Neoplasms

NCT06906471 2026-01-22

A Single-Arm, Blinded, Fluorescent PSMA Histopathology Trial of AS1986NS

Phase 1/2 Not yet recruiting

Adenocarcinoma, Prostatic Neoplasms

NCT07341737 2026-01-15

SL-28 for Advanced Solid Tumours

Phase 1/2 Not yet recruiting

BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Adenocarcinoma of Lung, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Head and Neck Neoplasms, Intestinal Neoplasms, Kidney Neoplasms, Liver Neoplasms, Lung Neoplasms, Melanoma, Neoplasm Metastasis, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

NCT06400160 2025-11-25

Clinical Trial of TB511 in Advanced Solid Tumors

Phase 1/2 Not yet recruiting

GastrointestinalGenitourinary

Carcinoma, Hepatocellular, Prostatic Neoplasms, Colorectal Neoplasms

NCT06607783 2025-08-28

PREDICT

Not yet recruiting

Disease, Prostatic Neoplasms

NCT07104110 2025-08-05

Study of QLH12016 in Combination With Novel Hormonal Agent in Subjects With Advanced Prostate Cancer

Phase 1/2 Not yet recruiting

Prostatic Neoplasms

NCT06194461 2025-06-27

LOCUS

Not yet recruiting

GastrointestinalGenitourinary

Carcinoma, Hepatocellular, Prostatic Neoplasms

NCT06866795 2025-03-10

Phase 1 Clinical Study of GT-220F in Subjects With Metastatic Castration Resistant Prostate Cancer (mCRPC)

Phase 1 Not yet recruiting

Prostatic Neoplasms

NCT06837896 2025-02-20

Efficacy and Safety Study of QLG1080 in Patients With Hormone-sensitive Advanced Prostate Cancer

Phase 3 Not yet recruiting

Prostatic Neoplasms

NCT06614751 2024-09-27

A PARG Inhibitor DAT-2645 Monotherapy in Patients with Advanced/Metastatic Solid Tumors Harboring BRCA1/2 Loss of Function Alterations And/or Other Defects in the DDR Pathway

Phase 1 Not yet recruiting

BreastGastrointestinalGenitourinaryGynecologic

Breast Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

NCT05411354 2024-01-02

Analyzing Clinical Trial Experiences of Prostate Cancer Patients

Not yet recruiting

Prostatic Neoplasms

NCT06183736 2023-12-27

CVL237 Tablets in the Treatment of Advanced Solid Tumors With PTEN Deficiency

Phase 2 Not yet recruiting

BreastDermatologicGastrointestinalGenitourinaryGynecologicThoracic

Breast Neoplasms, Lung Neoplasms, Melanoma, Prostatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

NCT06070272 2023-10-06

Determining Patterns In Trial Experiences of Recurrent Prostate Cancer Patients

Not yet recruiting

Prostatic Neoplasms

NCT06009549 2023-08-24

A Journey Into Participation Patterns Among Metastatic Prostate Cancer Patients

Not yet recruiting

Prostatic Neoplasms